Taxol and Idiopathic thrombocytopenic purpura - a phase IV clinical study of FDA data

Summary:

Idiopathic thrombocytopenic purpura is found among people who take Taxol, especially for people who are female, 50-59 old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Taxol and have Idiopathic thrombocytopenic purpura. It is created by eHealthMe based on reports of 30,994 people who have side effects when taking Taxol from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

With medical big data and AI algorithms, eHealthMe enables everyone to run phase IV clinical trial to detect adverse drug outcomes and monitor effectiveness. Our original studies have been referenced on 600+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Most recently, phase IV clinial trails for COVID 19 vaccines have been added, check here.



On Jun, 30, 2022

30,994 people reported to have side effects when taking Taxol.
Among them, 6 people (0.02%) have Idiopathic thrombocytopenic purpura.


What is Taxol?

Taxol has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 31,227 Taxol users for its effectiveness, alternative drugs and more.

What is Idiopathic thrombocytopenic purpura?

Idiopathic thrombocytopenic purpura (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting) is found to be associated with 1,307 drugs and 801 conditions by eHealthMe.

Number of Taxol and Idiopathic thrombocytopenic purpura reports submitted per year:

Could Taxol cause Idiopathic thrombocytopenic purpura?

Time on Taxol when people have Idiopathic thrombocytopenic purpura *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Idiopathic thrombocytopenic purpura when taking Taxol *:

  • female: 100 %
  • male: 0.0 %

Age of people who have Idiopathic thrombocytopenic purpura when taking Taxol *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 50 %
  • 50-59: 50 %
  • 60+: 0.0 %

Common drugs people take besides Taxol *:

  1. Tranxene: 2 people, 33.33%
  2. Solu-Medrol: 2 people, 33.33%
  3. Polaramine: 2 people, 33.33%
  4. Ketoprofen: 2 people, 33.33%
  5. Herceptin: 2 people, 33.33%
  6. Effexor: 2 people, 33.33%
  7. Taxotere: 1 person, 16.67%
  8. Gemzar: 1 person, 16.67%
  9. Carboplatin: 1 person, 16.67%
  10. Avastin: 1 person, 16.67%

Common side effects people have besides Idiopathic thrombocytopenic purpura *:

  1. Weakness: 1 person, 16.67%
  2. Intravascular Haemolysis (intravascular rupture of red blood cells with the release of haemoglobin and the cellular constituents into the plasma, or liquid portion of whole blood): 1 person, 16.67%
  3. Haemolytic Uraemic Syndrome (blood clotting disease caused by e. coli infection, birth control pills, pneumonia, medications, and more): 1 person, 16.67%
  4. Death: 1 person, 16.67%

Common conditions people have *:

  1. Breast Cancer Metastatic: 1 person, 16.67%

* Approximation only. Some reports may have incomplete information.

Do you take Taxol and have Idiopathic thrombocytopenic purpura?

Check whether Idiopathic thrombocytopenic purpura is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related studies

Alternative drugs to, pros and cons of Taxol:

Idiopathic thrombocytopenic purpura treatments and more:

COVID vaccines that are related to Idiopathic thrombocytopenic purpura:

How severe was Idiopathic thrombocytopenic purpura and when was it recovered:

Expand to all the drugs that have ingredients of paclitaxel:

Common drugs associated with Idiopathic thrombocytopenic purpura:

All the drugs that are associated with Idiopathic thrombocytopenic purpura:

Common conditions associated with Idiopathic thrombocytopenic purpura:

All the conditions that are associated with Idiopathic thrombocytopenic purpura:

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Taxol) and Taxol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: